 "GSK faces bribery investigation in Poland: report")
GlaxoSmithKline Plc is facing a criminal investigation in Poland for allegedly bribing doctors to promote its asthma drug Seretide, BBC Panorama reported on Sunday.
The BBC reported that 11 doctors and a GSK regional manager have been charged over alleged corruption between 2010 and 2012.
"The investigation found evidence of inappropriate communication in contravention of GSK policy by a single employee. The employee concerned was reprimanded and disciplined as a result," the drugmaker was quoted as saying.
GSK could not be reached immediately outside regular working hours.
According to the BBC, one doctor has admitted guilt and has been fined and given a suspended sentence.
GSK, Britain's biggest drugmaker, was accused by Chinese authorities in July of funnelling up to 3 billion yuan to doctors and officials to encourage them to use its medicines in a case that rocked the pharmaceuticals industry.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app